Position in JNJ
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$2,826,940
+$209,233 QoQ
Shares Held
11,131
+3.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#2,041
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SHEETS SMITH WEALTH MANAGEMENT holds $34,544,473 across 9 Drug Manufacturers - General names. JNJ ranks #4 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,264 | $17,108,670 | |
| 2 | AMGN |
Amgen Inc
|
17,231 | $6,239,689 | |
| 3 | ABBV |
AbbVie Inc.
|
14,811 | $3,727,040 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
11,131 | $2,826,940 | |
| 5 | MRK |
Merck & Co., Inc.
|
21,343 | $2,742,575 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,247 | $915,585 | |
| 7 | NVS |
Novartis AG
|
2,450 | $383,964 | |
| 8 | PFE |
Pfizer Inc
|
14,609 | $351,784 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,826,940 | 11,131 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $2,617,707 | 10,709 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $2,169,042 | 10,481 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,954,697 | 10,542 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $1,995,526 | 13,064 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $2,161,226 | 13,032 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,931,255 | 13,354 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $2,189,430 | 13,510 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,998,591 | 13,674 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $2,204,377 | 13,935 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,166,303 | 13,821 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,929,586 | 12,389 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $2,267,458 | 13,699 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,114,665 | 13,643 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $2,361,280 | 13,367 | Shares | Sole | 2023-03-08 | |
| 2022-09-30 | $2,182,816 | 13,362 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $2,317,215 | 13,054 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,409,441 | 13,595 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $2,352,041 | 13,749 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $2,250,018 | 13,932 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $2,447,542 | 14,857 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $2,433,366 | 14,806 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $2,273,826 | 14,448 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $2,172,605 | 14,593 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,966,851 | 13,986 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $1,839,885 | 14,031 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||